UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children
Condition: HIV Infection Intervention: Drug: dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen Sponsors: PENTA Foundation; Radboud University Medical Center; AMS-PHPT Research Collaboration; Baylor College of Medicine; University of Zimbabwe Clinical Research Centre (UZCRC); Clinton Health Access Initiative Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials